| Tuberculosis vaccine: A journey from BCG to present S Fatima, A Kumari, G Das, VP Dwivedi Life sciences 252, 117594, 2020 | 183 | 2020 |
| [6]-Gingerol exhibits potent anti-mycobacterial and immunomodulatory activity against tuberculosis A Bhaskar, A Kumari, M Singh, S Kumar, S Kumar, A Dabla, S Chaturvedi, ... International Immunopharmacology 87, 106809, 2020 | 62 | 2020 |
| Advances in adjunct therapy against tuberculosis: Deciphering the emerging role of phytochemicals S Fatima, A Kumari, VP Dwivedi MedComm 2 (4), 494-513, 2021 | 25 | 2021 |
| Epigenetic code during mycobacterial infections: therapeutic implications for tuberculosis S Fatima, A Kumari, M Agarwal, I Pahuja, V Yadav, VP Dwivedi, ... The FEBS Journal 289 (14), 4172-4191, 2022 | 20 | 2022 |
| Berberine governs NOTCH3/AKT signaling to enrich lung-resident memory T cells during tuberculosis I Pahuja, K Negi, A Kumari, M Agarwal, S Mukhopadhyay, B Mathew, ... PLoS Pathogens 19 (3), e1011165, 2023 | 19 | 2023 |
| Luteolin-mediated Kv1.3 K+ channel inhibition augments BCG vaccine efficacy against tuberculosis by promoting central memory T cell responses in mice DK Singh, VP Dwivedi, SP Singh, A Kumari, SK Sharma, A Ranganathan, ... PLoS pathogens 16 (9), e1008887, 2020 | 16 | 2020 |
| The 1, 2-ethylenediamine SQ109 protects against tuberculosis by promoting M1 macrophage polarization through the p38 MAPK pathway M Singh, S Kumar, B Singh, P Jain, A Kumari, I Pahuja, S Chaturvedi, ... Communications Biology 5 (1), 759, 2022 | 10 | 2022 |
| Withaferin A protects against primary and recurrent tuberculosis by modulating Mycobacterium-specific host immune responses A Kumari, I Pahuja, K Negi, A Ghoshal, S Mukopadhyay, M Agarwal, ... Microbiology Spectrum 11 (2), e00583-23, 2023 | 6 | 2023 |
| Biapenem, a carbapenem antibiotic, elicits mycobacteria specific immune responses and reduces the recurrence of tuberculosis I Pahuja, A Verma, A Ghoshal, S Mukhopadhyay, A Kumari, A Shaji, ... Microbiology Spectrum 11 (4), e00858-23, 2023 | 5 | 2023 |
| Antimicrobial Peptides in Tuberculosis: Insights into the Immunomodulatory Mechanisms A Kumari, G Mathur, G Sharma Chemical Biology Letters 12 (1), 1253-1253, 2025 | | 2025 |
| Correction: Luteolin-mediated Kv1.3 K+ channel inhibition augments BCG vaccine efficacy against tuberculosis by promoting central memory T cell responses in mice DK Singh, VP Dwivedi, SP Singh, A Kumari, SK Sharma, A Ranganathan, ... PLoS Pathogens 17 (8), e1009896, 2021 | | 2021 |
